ABLATION THERAPY9,10,11,12,13
"Ablation" is a technique where tissue is heated until it is no longer viable or alive. Various forms of ablation have been used
for nearly a century to treat a number of cancerous and precancerous conditions, as well as to control bleeding. The HALO ablation
technology is a very specific type of ablation, in which heat energy is delivered in a precise and highly-controlled manner.
Ablation therapy is performed in conjunction with upper endoscopy and the treatment is performed in an outpatient setting.
HOW DOES THE ABLATION TECHNOLOGY WORK?
The ablation technology consists of two different devices; the HALO360+ ablation catheter and the
HALO90 focal ablation device. The balloon-based HALO360+ device is capable of treating larger areas of circumferential
Barrett's esophagus, while the focal ablation device is used to treat smaller areas.
The proprietary technology incorporated in the HALO360 and the HALO90
Systems is designed to maximize clinical outcomes and completely remove the Barrett's epithelium without significant injury to
the underlying tissue.
 |
| Bipolar electrode array geometry precisely controls the depth of ablation to < 1 mm. |
-
Delivery of ablative energy in less than 1 second allows long or short segments of Barrett's to be treated quickly
-
Consistent application of bipolar energy uniformly removes the esophageal epithelium, reducing potential for buried glands and improving patient tolerability
-
Controlled treatment depth of less than 1,000 µm reduces risk of stricture formation, even after multiple energy applications
PRECISE DEPTH CONTROL
Barrett's epithelium is approximately 500 µm in thickness. The HALO Energy Generator and the HALO Ablation Catheter electrode
array are designed to work in concert to achieve a uniform, superficial depth of ablation of ~1,000 µm.
Human Esophagus Specimen (H&E Stain)

PREDICTABLE OUTCOME
In both porcine and human esophagectomy studies, the HALO technology has demonstrated removal of the esophageal epithelium without
significant injury to the submucosa when using the recommended treatment settings.
| |
|
|
|
|
Non-ablated esophagus Epithelium intact
|
|
48 hours Post-Ablation Absence of epithelium with preservation of lamina propria and muscularis mucosae.
|
References